Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 296

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 296
---
classified as
10,000 Class A Ordinary Shares upon the Share Re-classification. The Company further allotted and issued 8,990,000 Class A Ordinary Shares
at $899 and 1,000,000 Class B Ordinary Shares at $100, respectively to LTO. On September 10, 2024, certain strategic investors acquired
4,320,000 Class A Ordinary Shares and 480,000 Class B Ordinary Shares, respectively.

Holders of Class A Ordinary Shares and Class
B Ordinary Shares shall vote together as a single class on all resolutions of the shareholders and have the same rights except each Class
A Ordinary Share shall entitle its holder to one (1) vote and each Class B Ordinary Share shall entitle its holder to fifteen (15) votes.
Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof but Class
A Ordinary Shares are not convertible into Class B Ordinary Shares.

The Company considered the above transactions
as a part of the Company’s recapitalization prior to completion of its initial public offering, the Company has retroactively restated
all shares and per share data for all the periods presented.

Note 10 – Segment reporting

ASC 280, “Segment Reporting”,
establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational
structure as well as information about geographical areas, business segments and major customers in financial statements for details
on the Company’s business segments. The Company uses the “management approach” in determining reportable operating
segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision
maker, the Chief Executive Officer for making operating decisions and assessing performance as the source for determining the Company’s
reportable segments. Management, including the chief operating decision maker, reviews operation results by revenue, gross profit and
gross margin, operating expenses, and operating income of different products or services to make key decisions. Based on management’s
assessment, the Company has determined that it has only one operating segment.

All of the Company’s revenue is generated
in Hong Kong. All of the Company’s assets are located in Hong Kong.

Note 11 – Disaggregation of revenues

The Company disaggregates its revenues from
selling contract products and providing services. The following table presents revenue by category for the six months ended September
30, 2024 and 2023, respectively:

| As a point in time                |